Blog
RSS FeedPosted by Michael Wonder on 24 Mar 2016
CADTH calls for patient input on a submission from Takeda for Entyvio (vedolizumab)
23 March 2016 - CADTH has received the following notice of a pending submission from Takeda for Entyvio (vedolizumab) for use ...
Posted by Michael Wonder on 23 Mar 2016
CADTH calls for patient input on a submission from Gilead for sofosbuvir with velpatasvir
23 March 2016 - CADTH has received notice of a pending submission from Gileda for sofosbuvir with velpatasvir for the treatment ...
Posted by Michael Wonder on 23 Mar 2016
SMC allows wider use of Gedeon Richter's Esmya (ulipristal acetate)
23 March 2016 - The Scottish Medicines Consortium has approved funding for the use across NHS Scotland of a uterine fibroid ...
Posted by Michael Wonder on 23 Mar 2016
NICE consults on draft guidance for new cystic fibrosis treatment
23 March 2016 - NICE has issued draft guidance which does not recommend Orkambi (lumacaftor-ivacaftor marketed by Vertex Pharmaceuticals) for treating ...
Posted by Michael Wonder on 23 Mar 2016
The drug industry can help reduce cancer drug costs
21 March 2016 - Bach and colleagues’ article is particularly relevant because cancer drug expenditure is of major concern. ...
Posted by Michael Wonder on 23 Mar 2016
France to call for lower drug prices at G7
22 March 2016 - France will announce a campaign to lower the price of new medicines, hoping world powers at the ...
Posted by Michael Wonder on 22 Mar 2016
What can we expect from value-based funding of medicines? A retrospective study
22 March 2016 - Deciding on public funding for pharmaceuticals on the basis of value for money is now widespread. We ...
Posted by Michael Wonder on 22 Mar 2016
Confirmed 1 April 2016 prices resulting from 2016 April Cycle of Price Disclosure
22 March 2016 - Confirmed 1 April 2016 prices resulting from the 2016 April Cycle of Price Disclosure have now been ...
Posted by Michael Wonder on 21 Mar 2016
Call for NZ Government to fund HPV vaccine for boys
20 March 2016 - Throat-cancer patient Grant Munro paid for his son to be vaccinated against the sexually-transmitted HPV virus because ...
Posted by Michael Wonder on 21 Mar 2016
NICE recommends abiraterone acetate for prostate cancer
21 March 2016 - NICE has issued final guidance recommending abiraterone (marketed as Zytiga by Janssen) for some prostate cancer patients*. ...
Posted by Michael Wonder on 21 Mar 2016
NICE confirms support for Novartis' heart drug Entresto
20 March 2016 - Cost regulators for the National Health Service in England and Wales have reiterated their support for the ...
Posted by Michael Wonder on 20 Mar 2016
PBAC Drug Utilisation Sub Committee outcome statement
18 March 2016 - The outcome statement from the February 2016 PBAC Drug Utilisation Sub Committee (DUSC) meeting is now available ...
Posted by Michael Wonder on 20 Mar 2016
Crossing the line: NICE’s value for money threshold
9 March 2016 - John Appleby explains the link between the NICE threshold and the NHS budget and considers whether it ...
Posted by Michael Wonder on 19 Mar 2016
SMC announces more forthcoming submissions
18 March 2016 - The SMC has announced forthcoming submissions for the following medicines: carfilzomib (Kyprolis), dasatinib monohydrate (Sprycel), emtricitabine with ...
Posted by Michael Wonder on 19 Mar 2016
Additional public summary documents - PBAC November 2015 meeting
18 March 2016 - Additional public summary documents from the PBAC November 2015 meeting are now available on the PBS website. ...